Brief: Dyadic Announced An MoU With Bangladesh’s State-Owned Pharmaceutical Company To Facilitate Biopharmaceutical Research And Biomanufacturing Capacity
21/06/2023 13:45
June 21 (Reuters) - Dyadic International Inc DYAI.O :
* DYADIC ANNOUNCED AN MOU WITH BANGLADESH’S STATE-OWNED
PHARMACEUTICAL COMPANY TO FACILITATE BIOPHARMACEUTICAL RESEARCH
AND BIOMANUFACTURING CAPACITY
Source text for Eikon: ID:nGNX4WcTdK
Further company coverage: DYAI.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Dyadic International
See all newsDyadic International Inc reports results for the quarter ended June 30 - Earnings Summary
Dyadic International Inc expected to post a loss of 4 cents a share - Earnings Preview
Brief: Dyadic International - Develops C1 Cell Lines And Manufactures Bundibugyo Ebolavirus Antigens Within 15 Days
Brief: Dyadic Announces Continued Listing On The Nasdaq Capital Market
Brief: Dyadic And Scripps Research Collaborate On Rapid-Response Hantavirus Antibody And Vaccine Development